Medpace Holdings (MEDP) Change in Accured Expenses (2015 - 2026)

Medpace Holdings (MEDP) has reported Change in Accured Expenses for 12 consecutive years, with -$1.3 million the latest figure, recorded in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$1.3 million, up 94.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $118.9 million (up 700.75% YoY), and the FY2025 annual result was $97.1 million, up 475.07% from the prior year.
• Change in Accured Expenses was -$1.3 million for Q1 2026 at Medpace Holdings, down from $39.6 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $45.3 million in Q3 2025 and troughed at -$23.2 million in Q1 2025.
• Average Change in Accured Expenses over 5 years is $14.5 million, with a median of $19.3 million recorded in 2022.
• Year-over-year, Change in Accured Expenses tumbled 156.48% in 2023 and jumped 1241.54% in 2025.
• Over 5 years, Change in Accured Expenses stood at $4.6 million in 2022, then soared by 486.8% to $27.2 million in 2023, then sank by 89.14% to $2.9 million in 2024, then surged by 1241.54% to $39.6 million in 2025, then sank by 103.29% to -$1.3 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$1.3 million in Q1 2026, $39.6 million in Q4 2025, and $45.3 million in Q3 2025.